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Nontyphoidal Salmonella is a leading cause of sepsis in African children. Cytokine responses are central to the pathophysiology
of sepsis and predict sepsis outcome in other settings. In this study, we investigated cytokine responses to invasive nontyphoidal
Salmonella (iNTS) disease inMalawian children. We determined serum concentrations of 48 cytokines with multiplexed immu-
noassays inMalawian children during acute iNTS disease (n 111) and in convalescence (n 77). Principal component analysis
and logistic regression were used to identify cytokine signatures of acute iNTS disease. We further investigated whether these
responses are altered by HIV coinfection or severe malnutrition and whether cytokine responses predict inpatient mortality.
Cytokine changes in acute iNTS disease were associated with two distinct cytokine signatures. The first is characterized by in-
creased concentrations of mediators known to be associated with macrophage function, and the second is characterized by
raised pro- and anti-inflammatory cytokines typical of responses reported in sepsis secondary to diverse pathogens. These cyto-
kine responses were largely unaltered by either severe malnutrition or HIV coinfection. Children with fatal disease had a distinc-
tive cytokine profile, characterized by raised mediators known to be associated with neutrophil function. In conclusion, cytokine
responses to acute iNTS infection inMalawian children are reflective of both the cytokine storm typical of sepsis secondary to
diverse pathogens and the intramacrophage replicative niche of NTS. The cytokine profile predictive of fatal disease supports a
key role of neutrophils in the pathogenesis of NTS sepsis.
In sub-Saharan Africa, nontyphoidal Salmonella (NTS) causesinvasive and frequently fatal disease in young children andHIV-
infected adults (1). Invasive NTS (iNTS) disease typically mani-
fests as bacteremia, presenting with a syndrome of febrile illness
commonly complicated by sepsis (1, 2). In 2010, iNTS disease was
estimated to have caused 3.4 million episodes of illness globally,
resulting in nearly 700,000 deaths, the large majority of which
occurred in Africa (3). The high burden of morbidity andmortal-
ity associated with iNTS disease in Africa reflects inadequate con-
trol strategies. There is no NTS vaccine available, and expanding
multidrug resistance renders many commonly available antibiot-
ics ineffective (4). The delivery of new interventions to control
iNTS disease in Africa will be facilitated by an improved under-
standing of the biology of these infections.
The host immune response to sepsis is characterized by pro-
and anti-inflammatory changes, reflected in circulating peripheral
cytokine levels (5). This diverse host immune response is central
to the pathophysiology of bacteremia and sepsis, and interindi-
vidual differences in circulating cytokine profiles are associated
with sepsis outcome (6, 7). Increased concentrations of both pro-
inflammatory (e.g., tumor necrosis factor [TNF] [8], interleu-
kin-6 [IL-6] [9], and IL-8 [10]) and anti-inflammatory (e.g., IL-
1Ra [11], IL-10, and high IL-10/TNF ratios [6, 7]) cytokines in
patients with sepsis have been previously demonstrated to predict
mortality. While much of the characteristic sepsis-associated cy-
tokine response is seen regardless of its etiology, there is evidence
for pathogen specificity in cytokine responses during sepsis de-
spite causing clinically indistinguishable syndromes (12, 13). In
this study, we used multiplexed immunoassays to describe cyto-
kine profiles associated with acute NTS bacteremia in Malawian
children. We investigated whether these profiles are modified by
common comorbidities (HIV infection andmalnutrition) associ-
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ated with iNTS disease in African children and whether distinct
cytokine profiles in acute infection are predictive of mortality.
MATERIALS AND METHODS
Study site and participants.Queen Elizabeth Central Hospital (QECH),
Blantyre, is the largest government hospital in Malawi. Since the imple-
mentation of clinical bacterial culture services in 1998, all febrile children
withoutmalaria parasitemia and all childrenwith suspected sepsis regard-
less of malaria parasitemia are investigated with blood culture on admis-
sion to QECH. In 2006, 249 children were admitted to QECH with NTS
bacteremia. Children under 16 years of age were eligible for recruitment
into the study approximately 24 h after admission, following isolation of
NTS by blood culture. Bacterial culture from blood was performed with
the BacT/Alert 3D system (bioMérieux), and identification of Salmonella
and serotyping was done using API 20E kits (bioMérieux) and agglutinat-
ing antisera (Difco Laboratories).Plasmodium falciparumparasitemiawas
tested by thick and thin blood films. HIV status was determined using
Determine (Abbot Laboratories) and UniGold (Trinity Biotech) rapid
tests, andHIV infection was confirmed in children less than 18months of
age by PCR. Children with weight for height (children 60 months) or
body mass index for age (children 60 months) Z scores greater than 3
standard deviations belowWHOmedian values or children with bilateral
pedal edema (kwashiorkor) were classified as severely malnourished. Full
blood counts were performed using an HMX (Becton Coulter).
Of 249 children with NTS bacteremia admitted to QECH in 2006, 111
(45%) were recruited to the study and a blood sample was obtained dur-
ing their acute illness. Of the remaining 138 children, 25 died prior to
recruitment and 14 were discharged or left the hospital prior to their
blood culture results becoming available. For the other 99 children, con-
sent for blood sampling was not obtained (n  38), blood samples were
not collected for clinical reasons following recruitment (e.g., anemia re-
quiring transfusion; n  42), or children could not be located (n  19).
One hundred one of 111 children had Salmonella enterica serovar Typhi-
murium and 8 had S. Enteritidis isolated from their blood. Two Salmo-
nella isolates were untypeable with the available antisera. The median age
was 16 months (range, 4 to 72 months). Forty-eight of 109 children were
HIV infected (44%), of whom 2 were receiving antiretroviral therapy
(ART) at presentation. Twenty-nine of 103 children were severely mal-
nourished (28%). Only 6 children had malaria parasitemia; therefore,
comparisons were not made for children according to malaria status.
Fourteen of 111 children (12%) died following recruitment. This case
fatality is lower than that seen in unselected cases of acute iNTS in Mala-
wian children in 2006 (20%), and it reflects the high number of children
withNTS bacteremia that die following admission but prior to their blood
culture indicating a diagnosis of Gram-negative bacteremia. Sera for cy-
tokine quantificationwere collected during acute iNTS disease (median of
1 day following collection of blood culture; range, 0 to 5 days) in all 111
children and in convalescence (median interval, 43 days; range, 31 to 67
days) in 77. No children were recorded as having died during the period
following discharge. As part of routine clinical care, a peripheral blood
leukocyte count was obtained in 79 children during acute disease, with a
white blood cell differential count being performed in 52. Study partici-
pant characteristics are presented in Table 1.
Serum cytokine quantification. Sera were separated from clotted
blood within 2 h of venesection and stored at 80°C. Serum concentra-
tions of 48 cytokines (see Table S1 in the supplemental material) were
assayed using Bio-Plex Pro 21- and 27-plex human cytokine, chemokine,
and growth factor fluorescent bead-based assays (Bio-Rad Laboratories).
Paired acute- and convalescent-phase samples were assayed together. In
brief, antibody-coated fluorescent microspheres were incubated with
manufacturer-supplied cytokine standards and study sera, washed, and
incubated with detection antibody. Following washing, the microspheres
were incubated with streptavidin-conjugated phycoerythrin before data
acquisition on a Luminex-100 instrument (Bio-Rad Laboratories) using
Bio-Plex Manager 4.1.1 software (Bio-Rad). Cytokine measurements be-
low the detection limit of the assay were assigned values of the lower
detection limit for each cytokine andwere included in the analysis. At least
one multiplexed assay failed in the case of five samples (3 acute, 2 conva-
lescent), and these were excluded from analysis.
Statistical analysis. Paired acute- and convalescent-phase serum cy-
tokine concentrations were compared with paired Wilcoxon signed-rank
tests. Acute-phase serum cytokine concentrations in children with and
without HIV infection and severe malnutrition, and in children who sur-
vived and children who died, were compared using Mann-Whitney U
tests. P values were adjusted for multiple comparisons with Holm’s cor-
rections. Heat maps were generated using Gene Cluster v3.0 and visual-
ized in TreeView v1.60 (Michael Eisen, Stanford University). Following
log transformation of the cytokine concentrations, principal component
analysis (14) was performed using cytokines differing between groups of
interest (Padjusted 0.05). Principal components (PC)were extractedwith
eigenvalues of 1.0 and with at least three significantly associated cyto-
kines (factor loadings of0.4 or0.4) and were obliquely rotated. The
extracted principal components then were included in multivariable lo-
gistic regression models. Leukocyte counts were normalized prior to
analysis with appropriate transformations and correlated with inde-
pendent variables with linear regression. All statistical analyses were
performed in R.
Ethics approval. Ethical approval was granted by the College of Med-
icine Research and Ethics Committee, University of Malawi. Informed
written consent was obtained from the parents or guardians of each child.
RESULTS
Cytokine responses in acute iNTS disease. Serum cytokine con-
centrations during acute iNTS disease have a distinct profile com-
pared with that seen in convalescence (Fig. 1). Following correc-
tion for multiple association testing, serum concentrations of 27
TABLE 1 Characteristics and comorbidities of study participantsa
Parameter
Value by sample type
Acute
(n 111)
Convalescent
(n 77)
Demographics, comorbidity, and outcome
Age (mo; median, range) 16, 4–72 18, 4–72
Female (no., %) 52/111, 47 35/77, 45
HIV infected (no., %) 48/109, 44 32/77, 42
Severe malnutrition (no., %) 29/103, 28 17/72, 24
Malaria (no., %) 6/108, 6 5/75, 7
Inpatient mortality (no., %) 14/111, 12
Clinical status at admissionb (no., %)
Febrile 88/104, 85
Tachycardia 19/31, 61
Tachypnea 25/36, 69
BCS 5 9/104, 9
Respiratory distress (no., %) 30/81, 37
Full blood countc
Hemoglobin (g/dl; median, range) 8.0, 3.9–14.4
Leukocytes (109/liter; median, range) 8.0, 1.3–37.8
Neutrophils (109/liter; median, range) 2.7, 0.3–14.2
Lymphocytes (109/liter; median, range) 3.8, 0.3–10.3
a Participant characteristics for both acute- and convalescent-phase samples represent
status at initial presentation with acute invasive nontyphoidal Salmonella disease.
b Tachycardia and tachypnea were defined as rates greater than the 90th percentile for
age, and respiratory distress was defined as the presence of tracheal tug, intercostal or
subcostal recession, head bobbing, or nasal flaring. BCS, Blantyre coma score.
c Hemoglobin concentrations and white blood cell counts were determined in 93 and 79
participants, respectively, with acute disease. White blood cell differential counts were
reported in 52 participants with acute disease.
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of 48 measured cytokines are significantly altered (Padjusted 
0.05) during acute iNTS disease compared with those during
convalescence (Table 2). Of the cytokines previously associated
with acute disease, the levels of 25 of 27 were significantly in-
creased in acute disease (Fig. 2).
To better delineate the biological processes underlying these
cytokine changes, we included the 27 cytokines in a principal com-
ponent analysis of serum cytokine concentration changes in acute
iNTS disease. Two principal components (PC) with eigenvalues
greater than 1 were extracted which cumulatively explain 59% of
the variance in cytokine responses (Table 3). Using conditional
logistic regression, in 73 matched acute- and convalescent-phase
sample pairs, PC1iNTS (odds ratio [OR], 10.36; 95% confidence
interval [CI], 3.69 to 29.06; P  8.8  106) and PC2iNTS (OR,
7.26; 95% CI, 3.02 to 17.45; P  9.29  106) are significantly
associated with acute iNTS disease. The inspection of the factor
loadings of each principal component (Table 3) suggests that each
PC represents a qualitatively different component of the host im-
FIG 1 Serum cytokine changes in acute iNTS disease and in convalescence. Shown is a heat map of 48 serum cytokine concentrations in acute iNTS disease (left;
n 108) and in convalescence (right; n 75). Yellow color change represents increased cytokine concentration relative to the median for all samples, and blue
color change represents a decrease. Cytokines are ordered by unsupervised hierarchical clustering, with between-cytokine distances represented by the dendro-
gram on the left side of the heat map.
TABLE 2 Serum cytokine concentrations during acute iNTS disease and in convalescencea
Cytokine
Median (IQR) cytokine concn (pg/ml) P value
Acute Convalescent Unadjusted Adjusted
IL-18 1,232 (627–2,122) 345 (195–510) 1.6 1012 7.7 1011
CXCL10 17,922 (9,512–30,037) 5,093 (3,291–7,393) 1.2 1011 5.7 1010
NGF 10.1 (7.2–14.3) 5.7 (3.7–7.2) 1.3 1010 5.9 109
CCL27 1,096 (845–1,538) 699 (552–877) 1.9 1010 8.4 109
LIF 33.7 (9.0–61.9) 1.9 (1.9–12.6) 2.7 1010 1.2 108
CSF1 42.1 (28.1–73.9) 15.7 (10.8–19.6) 2.9 1010 1.2 108
HGF 2,063 (1,064–2,820) 704 (562–1,014) 3.8 1010 1.6 108
IL-6 43.6 (22.0–105.4) 8.8 (7.1–16.4) 9.4 1010 3.9 108
IL-2Ra 972 (568–1,664) 467 (264–732) 1.2 109 4.8 108
IL-8 36.3 (26.4–66.3) 18.4 (13.5–27.0) 1.4 109 5.4 108
IL-1Ra 782 (287–1,844) 187 (126–285) 4.4 109 1.7 107
IFN-2 164.7 (126.5–206.2) 113.1 (92.3–137.2) 6.1 109 2.3 107
IL-3 344.2 (178.8–467.6) 125.9 (74.3–183.7) 7.1 109 2.5 107
IL-12p40 666 (463–1,007) 322 (230–478) 2.2 108 7.9 107
CXCL12 256.2 (201.3–328.1) 146.2 (114.7–194.6) 3.8 108 1.3 106
LTA 6.2 (3.8–8.1) 3.0 (2.2–3.9) 2.1 107 6.8 106
CXCL9 12,444 (6,836–25,961) 6,116 (3,511–9,494) 5.0 107 1.6 105
KITLG 197.7 (123.1–262.7) 118.9 (98.1–147.4) 2.6 106 8.0 105
CCL7 47.1 (28.6–74.2) 24.1 (14.6–37.4) 2.9 106 8.6 105
IL-10 14.7 (7.5–34.7) 5.9 (4.4–10.5) 3.2 106 9.3 105
IL-1 2.6 (1.5–3.6) 1.4 (0.5–2.3) 4.5 106 1.3 104
IL-15 14.7 (2.2–24.8) 1.3 (1.3–9.3) 1.0 105 2.8 104
PDGF 3,954 (1,867–7,985) 7,433 (4,827–11,246) 1.7 105 4.5 104
CLEC11a 61,008 (41,516–105,760) 42,730 (33,827–59,077) 3.5 105 8.7 104
CSF3 43.1 (23.7–67.1) 22.9 (13.1–36.0) 4.2 105 1.0 103
IL-5 0.8 (0.1–1.9) 1.7 (0.1–2.9) 2.1 104 4.8 103
MIF 742 (476–1,226) 558 (333–764) 8.3 104 0.02
a Data from 146 participant samples (73 matched acute- and convalescent-phase sample pairs) are included in the analysis. Significance testing was performed with paired
Wilcoxon signed-rank tests, with P values adjusted for multiple comparisons with Holm step-down corrections. Serum cytokine concentrations significantly altered in acute disease
compared to those in convalescence (Padjusted 0.05; n 27) are displayed. IQR, interquartile range.
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mune response to iNTS disease. PC1iNTS is characterized by in-
creased concentrations of mediators and markers known to be
associated with macrophage function, with raised levels of cyto-
kines impacting their differentiation (colony-stimulating factor 1
[CSF1] and IL-3 [15]), migration (NGF, CXCL12 [16], and CCL7
[17]), activation (IL-12, IL-18 [18], and CXCL9 [19]), and sur-
vival (alpha interferon [IFN-] [20]). PC1iNTS is also character-
ized in part by raised circulating markers of T cell migration
(CCL27 [21]) and activation (IL-2R [22]). PC2iNTS is character-
ized by a cytokine profile typically described in patients with sep-
sis, with concomitantly raised proinflammatory (IL-6, IL-8,
CXCL10, and IL-15) and anti-inflammatory (IL-10 and IL-1Ra)
cytokines (23).
iNTS disease cytokine responses inHIV-coinfected andmal-
nourished children. Examination of the cytokine profiles in acute
iNTS disease does not demonstrate clear differences between
HIV-infected and uninfected children or between children with
and without severe malnutrition (Fig. 3). Indeed, following cor-
rection for multiple comparisons, no cytokine concentration was
significantly affected by nutritional status (data not shown). Only
IL-2 was found to vary with HIV status, with the IL-2 concentra-
tion in acute iNTS disease being significantly decreased in
HIV-infected children (median IL-2HIV infected level, 7.94 pg/ml;
IL-2
HIV uninfected
level, 16.93 pg/ml; Padjusted 0.006) (Fig. 3C).
Cytokine profiles in fatal iNTS disease. A comparison of the
cytokine profiles during acute iNTS disease between survivors and
children who died in the hospital following recruitment demon-
strates that fatal iNTS disease has a distinctive cytokine profile
(Fig. 4). Serum concentrations of 12 of 48 cytokines during acute
iNTS disease were significantly different in nonsurvivors than in
survivors (see Table S2 in the supplemental material), with all
differentially expressed cytokines being increased in children who
subsequently died (Fig. 4). We included these 12 cytokines in a
principal component analysis to identify any underlying structure
in this group of cytokines, which we hypothesized would be rep-
resentative of distinct immunological processes. Analysis revealed
two principal components with eigenvalues greater than 1 (Table
4), which cumulatively explain 74% of the variance in cytokine
responses associated with mortality. To test if either of these prin-
cipal components independently predicts mortality, we fitted a
multivariable logistic regression model of mortality including
both principal components as covariates. In this model,
PC2mortality (OR, 4.22; 95% CI, 1.63 to 12.24; P 0.005; see Table
S3), but not PC1mortality (OR, 1.64; 95% CI, 0.65 to 7.90; P 
0.448), is associatedwith iNTS diseasemortality inMalawian chil-
dren. To further investigate this observation, we fitted a second
multivariable logistic regression model of mortality including
PC2mortality, HIV infection, and malnutrition as covariates, dem-
FIG 2 Serum cytokine changes in acute iNTS disease and in convalescence. Shown is a radar plot of the serum concentrations of cytokines (n 27) significantly
differentiated between acute iNTS disease (blue; n 108) and convalescence (red; n 75). Lower serum cytokine concentrations plot toward the center of the
graph, and shaded areas represent 95% confidence intervals. Cytokine concentrations are normalized and standardized with rank-based inverse normal
transformations.
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onstrating that the observed association of PC2mortality (OR, 5.11;
95%CI, 2.29 to 14.18; P 3.6 104) with mortality is indepen-
dent of HIV infection and severe malnutrition (see Table S4).
Inspection of the factor loadings (Table 4) demonstrates that PC2
is characterized by increased IL-8 and HGF and perturbed IL-1
signaling with increased IL-1Ra and IL-1 levels, all factors asso-
ciated with neutrophil function. The coregulation of this group of
cytokines suggests that PC2mortality reflects the migration and ac-
tivation of neutrophils. Both IL-8 andHGF direct the recruitment
and activation of neutrophils at sites of inflammation, and signal-
ing via both cytokines is induced by IL-1 signaling (24, 25). To
further understand the role of this group of coregulated cytokines
in neutrophil function, we tested for an association with the
PC2mortality and peripheral blood neutrophil counts during acute
disease. Square-root-transformed neutrophil counts were signifi-
cantly associated by linear regression (P  8.6  104) (Fig. 4)
with PC2mortality during acute disease. This association appears to
be specific to circulating neutrophil numbers, with no significant
associations demonstrated between PC2mortality and log-trans-
formed circulating total leukocyte (P 0.51, n 79), monocyte
(P 0.39, n 52), or lymphocyte (P 0.39, n 52) numbers. In
amultiple-regressionmodel, PC2mortality is significantly associated
with neutrophil count independent of age, sex, malnutrition, and
HIV infection (P 0.04) (see Table S5).
DISCUSSION
In this study, we describe the cytokine profile associated with
acute iNTS disease in African children. The response is composed
of two biologically distinct principal components. The first group
of coregulated cytokines is consistent with a role for macrophage
differentiation, migration, and function during acute NTS bacte-
remia. The association of acute iNTS disease with a group of co-
regulated cytokines known to be involved with macrophage func-
tion is consistent with our understanding of iNTS pathogenesis.
NTS is a facultative intracellular pathogen, and the control of in-
tracellular NTS infection within macrophages is central to host
immunity to iNTS in both animal models and human disease
(26). In human disease, this is most clearly illustrated by Mende-
lian susceptibility to mycobacterial disease (MSMD). MSMD is a
genetically heterogeneous collection of primary immunodeficien-
cies with disseminated NTS disease reported in half of cases (27)
and in all of which intramacrophage control of NTS is compro-
mised (26).
The second group of coregulated cytokines, associated with
acute iNTS disease, appears to represent a less Salmonella-specific
immune response, with increased pro- and anti-inflammatory cy-
tokines typical of the dysregulated cytokine storm described for
patients with sepsis regardless of its etiology (5). The demonstra-
tion of concomitantly increased pro- and anti-inflammatory cy-
tokines at admission with acute iNTS disease is in keeping with
our current understanding of the pathophysiology of sepsis, in
which both responses are seen very early in the course of disease
(23).
It is striking that the cytokine response to acute iNTS disease in
Malawian childrenwas largely unaffected by the presence of either
severe malnutrition or HIV infection in this study. No cytokine is
significantly perturbed (following correction for multiple associ-
ation testing) during acute iNTS disease by the presence of severe
malnutrition. Only IL-2 is significantly increased in HIV-infected
children with iNTS during acute infection, despite only 2 of 48
HIV-infected children receiving ART prior to admission. This ob-
servation may reflect the study’s power to detect differentially ex-
pressed cytokines following correction for multiple association
testing, but it is in keeping with previously published data which
reportminimal changes in the cytokine response to sepsis inHIV-
infected and -uninfected individuals (28). This is noteworthy, as
HIV infection increases the risk of mortality secondary to sepsis
(29), and well-characterized cytokine perturbations are described
during both acute and chronic HIV infection (30). In contrast,
HIV-infectedMalawian childrenwith invasive pneumococcal dis-
ease (IPD) have plasma concentrations of CXCL8 and CCL2 that
are increased compared to those of HIV-uninfected children with
IPD (31). This difference is likely to be largely attributable to dif-
ferences in the invasive bacterial disease, as the large majority of
the children included in the IPD study had pneumococcal men-
ingitis rather than bacteremia.
A distinctive cytokine profile predicts case fatality in children
with acute NTS bacteremia. That cytokine profile is characterized
TABLE 3 Principal component analysis of serum cytokine
concentrations differentiating acute iNTS disease and convalescencea
Cytokine
Analysis resultb
PC1iNTS PC2iNTS
LTA 0.94 0.15
CSF1 0.92 0.03
NGF 0.88 0
IL-3 0.85 0.1
CCL7 0.83 0.03
LIF 0.83 0.06
IFN2 0.81 0
IL-2Ra 0.81 0.07
KITLG 0.81 0.1
IL-12p40 0.78 0.16
IL-18 0.77 0.07
CXCL9 0.72 0.1
CCL27 0.65 0.06
HGF 0.54 0.43
CXCL12 0.5 0.33
IL-1Ra 0.03 0.88
IL-6 0.06 0.85
CSF3 0.05 0.77
IL-10 0.13 0.72
CXCL10 0.07 0.7
IL-15 0.02 0.68
IL-8 0.24 0.6
CLEC11A 0.11 0.5
MIF 0.23 0.34
PDGF 0.12 0.3
IL-5 0.04 0.01
IL-1 0.18 0.33
Eigenvalue 10.26 5.62
Proportion variance 0.38 0.21
a Measurements of 27 cytokines in 146 participant samples (73 matched acute- and
convalescent-phase sample pairs) are included in the analysis.
b For each PC, the factor loading of each cytokine included in the analysis is displayed.
Factor loadings represent the correlation between each cytokine and a principal
component, varying between1 and	1. The larger the absolute value of a given factor
loading, the greater importance of that cytokine to the principal component. We define
influential cytokines for a given principal component as having a factor loading of0.4
or0.4. Cytokines with loadings in excess of
0.4 account for at least 16% of the
variance in the principal component. Influential cytokines for each principal
component are displayed in boldface.
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by increased HGF and IL-1 (IL-1 and IL-1Ra) signaling and in-
creased levels of IL-8. IL-1 signaling molecules include two IL-1
receptor agonists (IL-1 and IL-1) and one IL-1 receptor antag-
onist, IL-1Ra, which together determine the level of functional
IL-1 signaling via the type 1 IL-1 receptor (32). In contrast to
IL-1, IL-1 is constitutively expressed in nonhematopoietic cells
(33). This constitutive expression facilitates a rapid inflammatory
response to necrosis in awide variety of tissues (33). In response to
tissue necrosis, IL-1 signaling results in IL-8 production by en-
dothelial cells (34), which recruits neutrophils to sites of tissue
damage (24). IL-1Ra, a competitive inhibitor of IL-1 signaling, is
produced in parallel to IL-1 during the acute inflammatory re-
sponse (35) and antagonizes functional IL-1 signaling, including
IL-8 production (34).
HGF signaling via its cognate receptor tyrosine kinase, MET,
supports the proliferation, migration, and morphogenesis of epi-
thelial cells (36).More recently, however,HGF-MET signaling has
been demonstrated tomediate neutrophil transendothelialmigra-
tion at sites of inflammation (25). In addition to its stimulation of
IL-8 production by endothelial cells, endothelial activation by
IL-1 increases the expression ofMET by neutrophils (25). Taken
together, fatal iNTS disease is characterized by a cytokine profile
characteristic of neutrophil recruitment to sites of tissue damage.
The observation that this group of cytokines is also associatedwith
circulating neutrophil numbers suggests that these cytokines sup-
port not only tissue recruitment of neutrophils but also emer-
gency granulopoiesis during acute iNTS disease. This effect may
be indirect, and cytokines classically implicated in emergency
granulopoiesis (37) (e.g., CSF2, CSF3, and IL-6) are not associated
with the cytokine signature predictive of mortality. However,
there is evidence for the role of IL-1 signaling in reactive granulo-
poiesis in response to alum (38).
The association of a cytokine profile characteristic of neutro-
phil recruitment and activation is in keepingwith previous studies
evaluating predictive biomarkers of mortality in children with
sepsis. Both IL-1 and IL-1Ra are differentially expressed in sur-
vivors and nonsurvivors among children with sepsis (39) and IPD
(11), respectively. However, raised plasma IL-8 in particular is
well established as a predictor of mortality in children with sepsis.
Serum IL-8 levels are increased at admission to pediatric intensive
care units (PICU) in children with sepsis who subsequently die
(40). In a prospective study, serum IL-8 of220 pg/ml at admis-
sion to PICU had a 95% negative predictive value for mortality in
children with sepsis (10).
The association of IL-8 with case fatality suggests that the de-
terminants of mortality in iNTS disease considerably overlap
FIG 3 Serum cytokine responses to acute iNTS disease in African children with HIV infection and malnutrition. (A) Heat map of 48 serum cytokine
concentrations during acute iNTS disease in children with (right; n 27) and without (left; n 73) severe malnutrition. (B) Heat map of 48 serum cytokine
concentrations during acute iNTS disease in children with (right; n 47) and without (left; n 59) HIV coinfection. Yellow color change represents increased
cytokine concentration relative to the median for all samples, and blue color change represents a decrease. Cytokines are ordered by unsupervised hierarchical
clustering, with between-cytokine distances represented by the dendrogram on the left side of the heat map. (C) Serum IL-2 concentration (log transformed) in
acute iNTS disease in uninfected (left; n 47) and HIV-infected (right; n 59) children.
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those of undifferentiated sepsis. The data are also in keeping with
observations that highlight a role for neutrophils in the control of
invasive Salmonella infection. In African children, HIV infection
and hemolysis (most notably secondary to malaria and hereditary
hemolytic anemias) are important risk factors for iNTS disease
(1). In both of these cases, enhanced susceptibility to iNTS disease
appears in part to be secondary to impairment of neutrophil func-
tion, with HIV infection perturbing Th17-mediated recruitment
of neutrophils to the intestinal mucosa (41) and hemolysis im-
pairing neutrophil respiratory burst capacity (42).
A strength of this study is the recruitment of substantial num-
bers of childrenwith sepsis secondary to a single pathogen, reflect-
ing the importance of NTS as a cause of sepsis in African children.
For future studies, it will be particularly important to address
whether the cytokine signature predictive of mortality in iNTS
disease is generalizable to sepsis secondary to other pathogens and
to other populations. The use of multiplexed assays in this study
facilitates an unbiased assessment of cytokine responses to iNTS
disease but also imposes a burden of multiple-association testing
with a consequent loss of study power. The limitations placed on
study power by multiple-association testing may in part account
for our failure to replicate well-validated correlates of mortality in
sepsis (in particular, TNF [8], IL-6 [9], and IL-10 [6, 7]). Those
discrepancies, however, may equally reflect differences in patient
populations, causative pathogens, and sample collection timing.
Larger follow-up studies could further define differences in cyto-
FIG 4 Serum cytokine responses to acute iNTS disease in African children with fatal and nonfatal disease. (A) Heat map of 48 serum cytokine concentrations
during acute iNTS disease in children with nonfatal (left; n  94) and fatal (right; n  14) disease. Yellow color change represents increased cytokine
concentration relative to the median for all samples, and blue color change represents a decrease. Cytokines are ordered by unsupervised hierarchical clustering,
with between-cytokine distances represented by the dendrogram on the left side of the heat map. (B) Radar plot of the serum concentrations of cytokines (n
12) in acute iNTS disease significantly differentiated between fatal (blue; n 14) and nonfatal (red; n 94) disease. Lower serum cytokine concentrations plot
toward the center of the graph, and shaded areas represent 95% confidence intervals. Cytokine concentrations are normalized and standardized with rank-based
inverse normal transformations. (C) Scatter plot of peripheral blood neutrophil counts and PC2mortality scores in Malawian children (n 52) with acute iNTS
disease. The linear regression line is plotted (blue). Two children with neutrophil count data subsequently died (data points highlighted with red circles).
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kine responses in children with fatal disease and in groups of chil-
dren with iNTS-associated comorbidities. Recruitment and blood
sampling at admission (before a blood culture diagnosis of bacte-
remia is possible) is required to understand whether children who
die early in admission with iNTS disease have the same cytokine
profile as those who die later in admission.
In conclusion, circulating cytokine profiles of Malawian chil-
dren with acute iNTS disease, regardless of HIV coinfection and
nutritional status, are characterized by two coregulated groups of
cytokines which represent distinct immunological responses. The
first group is associated with the migration and activation of mac-
rophages and may reflect the replicative niche of Salmonella
within the macrophage. The second is characterized by concomi-
tant pro- and anti-inflammatory immune responses typical of
sepsis regardless of the causative pathogen. Children with fatal
iNTS disease have distinctive cytokine profiles during acute dis-
ease, characterized by a combination of dysregulated IL-1 signal-
ing, increased HGF levels, and increased IL-8 production. This
signature may well result in the perturbation of the infiltration
and activation of neutrophils in infected and damaged tissues and
is associated with increased circulating neutrophil numbers.
These findings are in keeping with our understanding of the biol-
ogy of sepsis in children andwith an increasing appreciation of the
potential role of neutrophil recruitment (41) and function (42) in
the control of Salmonella disease.
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